- Home
- ADAP vs GCV Comparison
ADAP vs GCV Comparison
Compare ADAP & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- GCV
- Stock Information
- Founded
- ADAP 2008
- GCV 1988
- Country
- ADAP United Kingdom
- GCV United States
- Employees
- ADAP 506
- GCV N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- GCV Finance/Investors Services
- Sector
- ADAP Health Care
- GCV Finance
- Exchange
- ADAP Nasdaq
- GCV Nasdaq
- Market Cap
- ADAP 75.5M
- GCV 75.6M
- IPO Year
- ADAP 2015
- GCV N/A
- Fundamental
- Price
- ADAP $0.29
- GCV $3.59
- Analyst Decision
- ADAP Strong Buy
- GCV
- Analyst Count
- ADAP 5
- GCV 0
- Target Price
- ADAP $1.83
- GCV N/A
- AVG Volume (30 Days)
- ADAP 777.8K
- GCV 57.9K
- Earning Date
- ADAP 05-13-2025
- GCV 01-01-0001
- Dividend Yield
- ADAP N/A
- GCV 13.04%
- EPS Growth
- ADAP N/A
- GCV N/A
- EPS
- ADAP N/A
- GCV N/A
- Revenue
- ADAP $178,032,000.00
- GCV N/A
- Revenue This Year
- ADAP N/A
- GCV N/A
- Revenue Next Year
- ADAP $69.81
- GCV N/A
- P/E Ratio
- ADAP N/A
- GCV N/A
- Revenue Growth
- ADAP 195.34
- GCV N/A
- 52 Week Low
- ADAP $0.20
- GCV $3.15
- 52 Week High
- ADAP $1.48
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- ADAP 51.38
- GCV 54.26
- Support Level
- ADAP $0.30
- GCV $3.53
- Resistance Level
- ADAP $0.32
- GCV $3.59
- Average True Range (ATR)
- ADAP 0.02
- GCV 0.07
- MACD
- ADAP 0.01
- GCV 0.02
- Stochastic Oscillator
- ADAP 67.44
- GCV 87.50
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.